Note: Ingredients listed on restricted chemical lists
EC/CAS
7553-56-2
Name of the chemical
Iodine (I)
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
EC/CAS
231-442-4
Name of the chemical
Iodine
Concentration
N/A
EC/CAS
231-791-2
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2021-05-26
Product name
Lugol"s solution
1.2.1 Relevant identified uses
Preparation for in vitro diagnostic use
1.2.2. Uses advised against
Any other than the above mentioned
supplier name
TestLine Clinical Diagnostics s.r.o
Emergency telephone
+420 224 919 293 or +420 224 915 402;
Icons in SDS
Company Information
company name
TestLine Clinical Diagnostics s.r.o
e-mail address of the competent person responsible for the Safety Data Sheet
pospisiljar@testlinecd.com, bl@studio2k.cz
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
2.1 Classification of the substance or mixture
The product is an in vitro diagnostic medical device in accordance with Directive 98/79/EC of the European Parliament and of the Council, is in the finished state and intended for the final user. It therefore does not apply to its Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) according to Article 1, par. 5d). They need not be classified, labelled or packaged in accordance with this Regulation.
CLP CLASSIFICATION
The product is classified as dangerous in the terms of the Regulation (EC) No 1272/2008 (CLP). STOT RE 2 H373 May cause damage to the thyroid through prolonged or repeated exposure. Route of exposure: Oral.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008: The product is classified and labelled according to the CLP regulation.
Hazard pictograms
d ~ GHS08
Hazardous Ingredients
potassium iodide
Hazard statements
H373 May cause damage to the thyroid through prolonged or repeated exposure. Route of exposure: Oral.
Precautionary statements
P260 Do not breathe vapours. P314 Get medical advice/attention if you feel unwell. P501 Dispose of contents/container to hazardous or special waste collection point.
Additional information
Restricted to professional users.
PBT Substances
The mixture does not contain substances classified at the date of preparation of the safety data sheet as PBT according to Regulation (EC) No 1907/2006 (REACH) in a concentration equal to or greater than 0.1 % by weight.
vPvB Substances
The mixture does not contain substances classified at the date of preparation of the safety data sheet as vPvB according to Regulation (EC) No 1907/2006 (REACH) in a concentration equal to or greater than 0.1 % by weight. Determination of endocrine-disrupting properties The mixture does not contain substances that have been identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0.1 % by weight.
